RxDoctor Payments Data

Erika Fromhold

Family · Santa Maria, CANPI 1417476060

Payments from drug & device makers

$4,225in general payments, 2019–2025

Across 143 payments — averaging $29.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$516
  • Amgen$408
  • Lilly USA, LLC$348
  • GSK$229
  • Boston Scientific$157
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$4,225100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,225 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$80,446
Trelegy ElliptaFluticasone/Umeclidin/Vilanter76$61,172
EliquisApixaban21$32,140
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,052$25,028
QuliptaAtogepant23$24,618
TrulicityDulaglutide12$24,279
ProliaDenosumab13$21,393
RybelsusSemaglutide15$15,537
JardianceEmpagliflozin13$15,122
UbrelvyUbrogepant11$14,722
Emgality PenGalcanezumab-Gnlm12$9,221
MyrbetriqMirabegron16$8,829
MovantikNaloxegol Oxalate19$7,640
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen239$7,310
Gabapentin414$7,120

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$516$95,98384 claims
GSKTrelegy Ellipta$229$61,17276 claims
AbbVieQulipta, Ubrelvy$1,557$39,33934 claims
PfizerEliquis$112$32,14021 claims
Lilly USA, LLCTrulicity$348$24,27912 claims
AmgenProlia$408$21,39313 claims
Boehringer IngelheimJardiance$143$15,12213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Santa Maria

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →